Dantrolene for Treatment of Suspected Neuroleptic Malignant Syndrome

J Emerg Nurs. 2018 Mar;44(2):207-209. doi: 10.1016/j.jen.2017.11.008.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Analgesics, Opioid / adverse effects
  • Anticonvulsants / adverse effects
  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use*
  • Benzodiazepines / adverse effects
  • Dantrolene / therapeutic use*
  • Diagnosis, Differential
  • Fentanyl / adverse effects
  • Haloperidol / adverse effects
  • Humans
  • Levetiracetam
  • Male
  • Middle Aged
  • Neuroleptic Malignant Syndrome / diagnosis*
  • Neuroleptic Malignant Syndrome / drug therapy*
  • Olanzapine
  • Phenytoin / adverse effects
  • Piracetam / adverse effects
  • Piracetam / analogs & derivatives

Substances

  • Analgesics, Opioid
  • Anticonvulsants
  • Antipsychotic Agents
  • Benzodiazepines
  • Levetiracetam
  • Phenytoin
  • Dantrolene
  • Haloperidol
  • Olanzapine
  • Fentanyl
  • Piracetam